COVID-19 Research with Ella

First, see how Simple Plex assays on the Ella^TM platform are used for COVID-19 research. Next, meet Ella and request pricing. Finally, choose the Simple Plex Assay that best meets your needs.

Simple Plex Assays for COVID-19 Research: From Your Peers
Simple Plex Cytokine Panels
Simple Plex Applications
View Complete Simple Plex Assay Menu

Real-Time Biological Phenotyping

When researching an acute SARS-CoV-2 infection and the resulting and deadly COVID-19 disease, speed and data quality are key. Ella™ enables cytokine and pro-inflammatory biomarker immunoassays in a multianalyte, automated and standardized format. Get the most reliable immunoassay results in real time with Ella.

After loading the cartridge, data is available in just 75 minutes, getting you to critical decision points faster
Factory calibrated cartridges and built-in standard curves minimize inter-lot variability allowing you to get the same measurement anywhere
80% reduction in manual steps eliminates operator error and inconsistent results

Meet Ella and Request Pricing

How Ella Is Helping During the COVID-19 Pandemic

Ella is at the forefront of the fight against COVID-19. The Human Immune Monitoring Center at Mount Sinai is leveraging the high-quality data and real-time results of Ella to understand if an immunologic response during COVID-19 is turning deadly. This insight is helping them determine if novel immuno-modulating therapies have the potential to mediate response to the virus.

Watch this virtual meeting organized by the NIH and FDA, to learn more about the role of cytokines in COVID-19 and how researchers at Mount Sinai established a rapid and quantitative cytokine test on Ella to obtain actionable immune monitoring data during the management of COVID-19 patients.

Watch the Cytokines in COVID-19 Meeting

COVID-19 research virtual meeting using automated ELISA system Ella

Watch Mount Sinai’s Miriam Merad, M.D., Ph.D. discuss the progress they’ve made using Ella for real-time immune profiling of the hyperinflammatory response during COVID-19 in this webinar.

Immune Profiling in COVID Webinar

Webinar on how Mount Sinai uses automated immunoassay platform Ella for Covid-19 research

Researchers at the Ichan School of Medicine at Mount Sinai published in Nature Medicine using The Cytokine Storm Panel on Ella! Read their work, entitled, “An Inflammatory cytokine signature predicts COVID-19 severity and survival”.

Inflammatory Cytokine Signature and COVID-19 Publication

Dr. Bermejo Martin discusses host response to COVID infection using Simple Plex assays on Ella

Profiling Host Responses In COVID-19 Infections: Accelerating Biomarker Research With Ella

"A major advantage of Ella is that it’s very easy to use with virtually no maintenance, and it’s really fast. Simply dilute your sample and you’re ready to go—without the need for manual preparations that can take time and add user variability."

- Dr. Jesús F Bermejo-Martín, Principal Investigator, Institute of Biomedical Research of Salamanca (IBSAL)/Hospital Universitario Río Hortega de Valladolid

Profiling Host Responses in COVID Story

Michael Matthay uses Ella to identify biomarkers important in acute respiratory failure and sepsis

Ella Promises Better Clinical Care For Acute Respiratory Failure And Sepsis

"Timely results from Ella have the potential to direct treatment for acute diseases where administration needs to take place in a matter of hours."

- Michael Matthay, M.D., Ph.D., Professor of Medicine, University of California San Francisco

Acute Respiratory Failure and Sepsis Story

Characterizing T-Cell Immune Responses Against Sars-Cov-2 With Ella

"Ella is a simple and fast immunoassay platform that would be ideal for implementation in higher biosafety facilities, like BSL-3, to study the acute phase of SARS-CoV-2 infection."

- Anthony Tanoto Tan, Ph.D., Senior Research Fellow, Duke-NUS Medical School, Singapore

T Cell Immune Response Against COVID Story

References

Le Bert et al. (2021) Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 Infection J. Exp. Med. 218:e20202617. PMID: 33646265.
Mandel et al. (2020) Cytokine prediction of mortality in COVID19 patients Cytokine 134:155190. PMID: 32673995.
Bordoni et al. (2020) An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19 Clinical Infectious Diseases 21:2272. PMID: 32407466.
Agrati et al. (2020) Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19) Cell Death & Differentiation 27:3196. PMID: 32514047.

Simple Plex COVID-19 Cytokine Storm Panel

Measure key inflammation markers that are indicative of pathologic inflammatory response with a high-quality multianalyte assay. The 16x4 COVID-19 Cytokine Storm Panel is perfect for batching small numbers of samples and getting results fast.

COVID-19 Cytokine Storm Panel Markers

Simple Plex™ Cytokine Screening Panel

The 32x8 Multiplex Cytokine Screening Panel gives you deep insight into an immunological response across a spectrum of critical markers. Get up to 256 results in just 90 minutes. Learn more about the multiplex cartridge.

Cytokine Screening Panel Markers

In response to the global COVID-19 pandemic, the COVID-19 Cytokine Storm Panel and Multiplex Cytokine Screening Panel are available off the shelf Off-the-shelf cartridges ship within 48 hours in the continental US.

DISCLAIMER: The Ella™ automated immunoassay platform is currently offered For Research Use Only; Not for Use in Diagnostic Procedures.

Bio-Techne's Tools For Coronavirus Research

As a leading company in the life sciences research sector, Bio-Techne develops products and resources to support coronavirus research, including reagents and platforms for SARS-CoV-2 detection, cytokine monitoring, and drug discovery. These tools help the scientific community better understand the mechanisms of infection and develop effective treatments. Learn more about Bio-Techne's portfolio or products for Coronavirus Research.

Explore More COVID-19 Research Tools